Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided bupivacaine liposome pudendal nerve block vs local infiltration for post-hemorrhoidectomy pain
ChiCTR2600120443Phase 4Recruiting
- Sponsor
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in post-hemorrhoidectomy pain (2 arms), sponsored by Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. Primary endpoint: Postoperative pain intensity (NRS score). Started Mar 2026; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
post-hemorrhoidectomy pain
Beyond the preview
Go deeper on ChiCTR2600120443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600120443.